U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
TRALOKINUMAB
GK1LYB375A
US Approved Rx (2021)
First approved in 2021
General
Names
7
Classification
3
Identifiers
11
Subunits
4
Related Substances
1
TRALOKINUMAB
GK1LYB375A
US Approved Rx (2021)
First approved in 2021
General
Approval Year
2021
460
Names
7
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
TRALOKINUMAB
Official Name
English
CAT-354
Preferred Name
English
TRALOKINUMAB [JAN]
Common Name
English
TRALOKINUMAB [USAN]
Common Name
English
Tralokinumab [WHO-DD]
Common Name
English
Showing 1 to 5 of 7 entries
Previous
1
2
Next
Classification
3
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated/Withdrawn
ORPHAN DRUG
Designated/Withdrawn
Treatment of idiopathic pulmonary fibrosis
FDA ORPHAN DRUG
373812
Withdrawn
EU ORPHAN DRUG
Withdrawn
Treatment of idiopathic pulmonary fibrosis
EU-Orphan Drug
EU/3/12/1061
Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Monoclonal Antibody
NCI_THESAURUS
C20401
Showing 1 to 3 of 3 entries
Previous
1
Next
Identifiers
11
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
SMS_ID
100000175358
PRIMARY
WIKIPEDIA
TRALOKINUMAB
PRIMARY
FDA UNII
GK1LYB375A
PRIMARY
ChEMBL
CHEMBL1743081
PRIMARY
DAILYMED
GK1LYB375A
PRIMARY
Showing 1 to 5 of 11 entries
Previous
1
2
3
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
GK1LYB375A
TRALOKINUMAB
